| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44029873 | HTLV-1 | ENSG00000162989.5 | protein_coding | KCNJ3 | No | No | 3760 | D2X9V0 D2XBF0 P48549 |
| TVIS44044467 | HTLV-1 | ENSG00000162989.5 | protein_coding | KCNJ3 | No | No | 3760 | D2X9V0 D2XBF0 P48549 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | KCNJ3 |
|---|---|
| DrugBank ID | DB08954 |
| Drug Name | Ifenprodil |
| Target ID | BE0001028 |
| UniProt ID | P48549 |
| Regulation Type | antagonist |
| PubMed IDs | 16123769 |
| Citations | Kobayashi T, Washiyama K, Ikeda K: Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil. Neuropsychopharmacology. 2006 Mar;31(3):516-24. doi: 10.1038/sj.npp.1300844. |
| Groups | Investigational; Withdrawn |
| Direct Classification | 4-benzylpiperidines |
| SMILES | CC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL305187 |
